Fri, May 10, 2024
Thu, May 9, 2024
Wed, May 8, 2024

Leland Gershell Maintained (VRDN) at Buy with Decreased Target to $31 on, May 9th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-31-on-may-9th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $36 to $31 on, May 9th, 2024.

Leland has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Leland's Rating of Hold.



This is the rating of the analyst that currently disagrees with Leland


  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024

Publication Contributing Sources